161 related articles for article (PubMed ID: 14499859)
1. Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor oxypurinol in failing rat myocardium.
Kögler H; Fraser H; McCune S; Altschuld R; Marbán E
Cardiovasc Res; 2003 Sep; 59(3):582-92. PubMed ID: 14499859
[TBL] [Abstract][Full Text] [Related]
2. Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy.
Minhas KM; Saraiva RM; Schuleri KH; Lehrke S; Zheng M; Saliaris AP; Berry CE; Barouch LA; Vandegaer KM; Li D; Hare JM
Circ Res; 2006 Feb; 98(2):271-9. PubMed ID: 16357304
[TBL] [Abstract][Full Text] [Related]
3. Preservation of cardiac contractility after long-term therapy with oxypurinol in post-ischemic heart failure in mice.
Tan Z; Dai T; Zhong X; Tian Y; Leppo MK; Gao WD
Eur J Pharmacol; 2009 Oct; 621(1-3):71-7. PubMed ID: 19737552
[TBL] [Abstract][Full Text] [Related]
4. Role of xanthine oxidoreductase in the reversal of diastolic heart failure by candesartan in the salt-sensitive hypertensive rat.
Yamamoto E; Kataoka K; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ogawa H; Kim-Mitsuyama S
Hypertension; 2007 Oct; 50(4):657-62. PubMed ID: 17709654
[TBL] [Abstract][Full Text] [Related]
5. Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts.
Naumova AV; Chacko VP; Ouwerkerk R; Stull L; Marbán E; Weiss RG
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H837-43. PubMed ID: 16183726
[TBL] [Abstract][Full Text] [Related]
6. Apelin increases contractility in failing cardiac muscle.
Dai T; Ramirez-Correa G; Gao WD
Eur J Pharmacol; 2006 Dec; 553(1-3):222-8. PubMed ID: 17055480
[TBL] [Abstract][Full Text] [Related]
7. Novel myofilament Ca2+-sensitizing property of xanthine oxidase inhibitors.
Pérez NG; Gao WD; Marbán E
Circ Res; 1998 Aug; 83(4):423-30. PubMed ID: 9721699
[TBL] [Abstract][Full Text] [Related]
8. The effects of propofol on the contractility of failing and nonfailing human heart muscles.
Sprung J; Ogletree-Hughes ML; McConnell BK; Zakhary DR; Smolsky SM; Moravec CS
Anesth Analg; 2001 Sep; 93(3):550-9. PubMed ID: 11524317
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy.
Baldus S; Müllerleile K; Chumley P; Steven D; Rudolph V; Lund GK; Staude HJ; Stork A; Köster R; Kähler J; Weiss C; Münzel T; Meinertz T; Freeman BA; Heitzer T
Free Radic Biol Med; 2006 Oct; 41(8):1282-8. PubMed ID: 17015175
[TBL] [Abstract][Full Text] [Related]
10. Chronic xanthine oxidase inhibition following myocardial infarction in rabbits: effects of early versus delayed treatment.
Zhao L; Roche BM; Wessale JL; Kijtawornrat A; Lolly JL; Shemanski D; Hamlin RL
Life Sci; 2008 Feb; 82(9-10):495-502. PubMed ID: 18215719
[TBL] [Abstract][Full Text] [Related]
11. Role of xanthine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage.
Das DK; Engelman RM; Clement R; Otani H; Prasad MR; Rao PS
Biochem Biophys Res Commun; 1987 Oct; 148(1):314-9. PubMed ID: 2823807
[TBL] [Abstract][Full Text] [Related]
12. Why do most human liver cytosol preparations lack xanthine oxidase activity?
Barr JT; Choughule KV; Nepal S; Wong T; Chaudhry AS; Joswig-Jones CA; Zientek M; Strom SC; Schuetz EG; Thummel KE; Jones JP
Drug Metab Dispos; 2014 Apr; 42(4):695-9. PubMed ID: 24430612
[TBL] [Abstract][Full Text] [Related]
13. Effects of cantharidin on force of contraction and phosphatase activity in nonfailing and failing human hearts.
Linck B; Boknik P; Knapp J; Müller FU; Neumann J; Schmitz W; Vahlensieck U
Br J Pharmacol; 1996 Oct; 119(3):545-50. PubMed ID: 8894176
[TBL] [Abstract][Full Text] [Related]
14. Xanthine oxidase contributes to mechanical ventilation-induced diaphragmatic oxidative stress and contractile dysfunction.
Whidden MA; McClung JM; Falk DJ; Hudson MB; Smuder AJ; Nelson WB; Powers SK
J Appl Physiol (1985); 2009 Feb; 106(2):385-94. PubMed ID: 18974366
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression and activity of xanthine oxidoreductase in the failing heart.
de Jong JW; Schoemaker RG; de Jonge R; Bernocchi P; Keijzer E; Harrison R; Sharma HS; Ceconi C
J Mol Cell Cardiol; 2000 Nov; 32(11):2083-9. PubMed ID: 11040111
[TBL] [Abstract][Full Text] [Related]
16. Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart.
Saavedra WF; Paolocci N; St John ME; Skaf MW; Stewart GC; Xie JS; Harrison RW; Zeichner J; Mudrick D; Marbán E; Kass DA; Hare JM
Circ Res; 2002 Feb; 90(3):297-304. PubMed ID: 11861418
[TBL] [Abstract][Full Text] [Related]
17. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta2 -adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling.
Molenaar P; Savarimuthu SM; Sarsero D; Chen L; Semmler AB; Carle A; Yang I; Bartel S; Vetter D; Beyerdörfer I; Krause EG; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):11-28. PubMed ID: 17295024
[TBL] [Abstract][Full Text] [Related]
18. Selective contractile dysfunction of left, not right, ventricular myocardium in the SHHF rat.
Janssen PM; Stull LB; Leppo MK; Altschuld RA; Marbán E
Am J Physiol Heart Circ Physiol; 2003 Mar; 284(3):H772-8. PubMed ID: 12424099
[TBL] [Abstract][Full Text] [Related]
19. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure.
Ekelund UE; Harrison RW; Shokek O; Thakkar RN; Tunin RS; Senzaki H; Kass DA; Marbán E; Hare JM
Circ Res; 1999 Sep; 85(5):437-45. PubMed ID: 10473673
[TBL] [Abstract][Full Text] [Related]
20. Chronic xanthine oxidase inhibition prevents myofibrillar protein oxidation and preserves cardiac function in a transgenic mouse model of cardiomyopathy.
Duncan JG; Ravi R; Stull LB; Murphy AM
Am J Physiol Heart Circ Physiol; 2005 Oct; 289(4):H1512-8. PubMed ID: 15863459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
